Filed Under: Onglyza News – Lawsuits, Settlements, Information

Top Class Action Pharmaceutical Drug Lawsuits in 2017

Class action lawsuits are frequently filed against pharmaceutical companies for serious complications and harm caused by prescription medications. This article lists the top class action drug lawsuits pending in courts throughout the United States in 2017.

File An Onglyza Heart Attack Lawsuit

Onglyza (saxagliptin) was approved by the U.S. Food and Drug Administration in 2009 as a DPP-4 inhibitor created by AstraZeneca to combat the effects of type 2 diabetes.

Onglyza TV Commercials – Heart Attack Lawsuits

You may have recently seen an advertisement on television about Onglyza and the potential complications that are caused by taking the dangerous drug. These commercials are airing because recent studies have identified this drug to have potentially dangerous and life threatening side effects, including heart attacks. Several lawsuits have been filed in the past few […]

Study: Januvia and Onglyza Linked to Increase in Cancer Metastasis

Type 2 diabetes drugs categorized as DPP-4 inhibitors have been reported to carry an increase risk of cancer metastasis according to a study tested on mice. According to, the study involved Januvia (sitagliptin) and Onglyza (saxagliptin) being exposed to the test mice. The tests showed an increase in cancer metastasis, but did not show an […]